 |
1AB9 |
CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN |
D |
CB |
|
|
 |
1AD8 |
COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY |
L |
H |
|
|
 |
1AFQ |
CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR |
A |
BC |
|
|
 |
1AY6 |
THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF |
L |
H |
|
|
 |
1BA8 |
THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES |
A |
B |
|
|
 |
1BAI |
Crystal structure of Rous sarcoma virus protease in complex with inhibitor |
C |
A |
Acid proteases |
|
 |
1BB0 |
THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES |
A |
D |
|
|
 |
1BCU |
ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN |
L |
H |
|
|
 |
1BJR |
COMPLEX FORMED BETWEEN PROTEOLYTICALLY GENERATED LACTOFERRIN FRAGMENT AND PROTEINASE K |
I |
E |
Subtilisin-like |
|
 |
1C4U |
SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES. |
1 |
2 |
|
|
 |
1CA8 |
THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES |
A |
D |
|
|
 |
1CJR |
X-RAY CRYSTALLOGRAPHIC STUDIES OF DENATURATION IN RIBONUCLEASE S |
A |
B |
|
|
 |
1CLV |
YELLOW MEAL WORM ALPHA-AMYLASE IN COMPLEX WITH THE AMARANTH ALPHA-AMYLASE INHIBITOR |
I |
A |
TIM beta/alpha-barrel |
|
 |
1D5D |
The role of phenylalanine 8 in the stabilization of the s protein-s peptide interaction: packing and cavities |
A |
B |
|
|
 |
1D5H |
Rnase s(f8a). mutant ribonucleasE S. |
A |
B |
|
|
 |
1DIT |
COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN |
L |
H |
|
|
 |
1DLK |
CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR |
A |
C |
Trypsin-like serine proteases |
|
 |
1DM4 |
SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16) |
C |
B |
|
|
 |
1E8N |
PROLYL OLIGOPEPTIDASE FROM PORCINE BRAIN, MUTANT, COMPLEXED WITH PEPTIDE |
I |
A |
alpha/beta-Hydrolases |
|
 |
1EB1 |
COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N-METHYL-ARGININE INHIBITOR |
L |
H |
|
|
 |
1F7A |
HOW DOES A SYMMETRIC DIMER RECOGNIZE AN ASYMMETRIC SUBSTRATE? A SUBSTRATE COMPLEX OF HIV-1 PROTEASE. |
P |
A |
Acid proteases |
|
 |
1FIW |
THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA |
L |
A |
|
|
 |
1G30 |
THROMBIN INHIBITOR COMPLEX |
A |
B |
|
|
 |
1G32 |
THROMBIN INHIBITOR COMPLEX |
A |
B |
|
|
 |
1G37 |
CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE |
B |
A |
Trypsin-like serine proteases |
|
 |
1GI7 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI8 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GI9 |
A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE |
A |
B |
|
|
 |
1GJ4 |
SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN |
L |
H |
|
|
 |
1GJ7 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJ8 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJ9 |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJA |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJB |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJC |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GJD |
ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS |
A |
B |
|
|
 |
1GL1 |
STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA |
J |
B |
Trypsin-like serine proteases |
|
 |
1H9H |
COMPLEX OF EETI-II WITH PORCINE TRYPSIN |
I |
E |
Trypsin-like serine proteases |
|
 |
1HBT |
HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR |
L |
H |
|
|
 |
1HXE |
SERINE PROTEASE |
I |
H |
|
|
 |
1ID5 |
CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN |
L |
H |
|
|
 |
1J7Z |
Osmolyte Stabilization of Ribonuclease |
A |
B |
|
|
 |
1J80 |
Osmolyte Stabilization of RNase |
A |
B |
|
|
 |
1J81 |
Osmolyte Stabilization of RNase |
A |
B |
|
|
 |
1J82 |
Osmolyte Stabilization of RNase |
A |
B |
|
|
 |
1JBU |
Coagulation Factor VII Zymogen (EGF2/Protease) in Complex with Inhibitory Exosite Peptide A-183 |
X |
H |
Trypsin-like serine proteases |
|
 |
1JQ8 |
Design of specific inhibitors of phospholipase A2: Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Leu-Ala-Ile-Tyr-Ser at 2.0 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
 |
1JQ9 |
Crystal structure of a complex formed between phospholipase A2 from Daboia russelli pulchella and a designed pentapeptide Phe-Leu-Ser-Tyr-Lys at 1.8 resolution |
P |
A |
Phospholipase A2. PLA2 |
|
 |
1JWY |
CRYSTAL STRUCTURE OF THE DYNAMIN A GTPASE DOMAIN COMPLEXED WITH GDP, DETERMINED AS MYOSIN FUSION |
C |
AB |
P-loop containing nucleoside triphosphate hydrolases |
|
 |
1JX2 |
CRYSTAL STRUCTURE OF THE NUCLEOTIDE-FREE DYNAMIN A GTPASE DOMAIN, DETERMINED AS MYOSIN FUSION |
C |
BD |
P-loop containing nucleoside triphosphate hydrolases |
|